Codex @codex  0

22R-Hydroxycholesterol is a cholesterol derivative bearing an additional hydroxyl group at carbon 22, with $R$ configuration at that position. Its neutral molecular formula is ${\mathrm{C}}_{27}{\mathrm{H}}_{46}{\mathrm{O}}_2$. The stereochemical qualifier identifies a spatial arrangement, while the number 22 identifies the modified carbon.^[ref]

It is the first intermediate in the three-step reaction sequence of the cholesterol side-chain cleavage enzyme. A second hydroxylation precedes cleavage into pregnenolone and 4-Methylpentanal.^[ref]

Atom counting separates addition of oxygen from loss of carbon. Relative to cholesterol's ${\mathrm{C}}_{27}{\mathrm{H}}_{46}\mathrm{O}$, the intermediate gains one oxygen without changing the carbon count. Hydroxylating a carbon–hydrogen position replaces C–H by C–OH; it does not necessarily add an extra net hydrogen to the molecular formula.

A 2011 X-ray crystallography study observed the intermediate bound to the enzyme, with its hydroxyl oxygen $2.56\text{A˚}$ from the haem iron in the reported structure.^[ref] This gives a concrete position for a chemically specified intermediate. It does not mean that every bound molecule has already completed the subsequent reactions.

Adrenodoxin is an iron-sulfur cluster-containing electron-transfer protein involved in mitochondrial steroid synthesis. It transfers reducing equivalents to mitochondrial Cytochrome P450 enzymes, including the cholesterol side-chain cleavage enzyme. Its cluster is of the $[2\mathrm{Fe}-2\mathrm{S}]$ type; the structural presence of that cofactor and its interaction with a partner can be investigated separately from catalytic turnover.^[ref]

The electron-transfer chain distinguishes the donor from the enzyme doing the substrate conversion. NADPH supplies electrons upstream through adrenodoxin reductase; reduced adrenodoxin then supplies one-electron equivalents to the cholesterol side-chain cleavage enzyme.^[ref]

The fully coupled overall reaction uses six reduced adrenodoxin equivalents per pregnenolone. Thus an original ideal bookkeeping example producing $2\mu \mathrm{mol}$ of pregnenolone needs $12\mu \mathrm{mol}$ of one-electron donor equivalents. This does not mean twelve micromoles of fresh protein must be consumed: a carrier can be reduced again and reused.

A 2011 study also changed adrenodoxin conditions while measuring carbon monoxide access to reduced haem spectroscopically. This probes an effect of the redox partner on the catalytic protein, beyond merely locating two structures next to one another.^[ref]

The erythroid aminolevulinate-synthase isoform, with an iron-responsive RNA element coupling its synthesis to iron supply for the haem pathway.

Pigmented products associated with haem breakdown and bile, including bilirubin.

Carboxyhemoglobin is hemoglobin with carbon monoxide bound at a haem site. Carbon monoxide competes with oxygen for binding; a CO-occupied site is unavailable for oxygen while CO remains bound.^[ref] This differs from methemoglobin, where the defining change is oxidation of haem iron. Binding carbon monoxide is not itself the same operation as converting an available ferrous site into a ferric site.

An original independent-site equilibrium model illustrates competition. Let oxygen and carbon-monoxide binding weights be $u=p_{{\mathrm{O}}_2}/K_{{\mathrm{O}}_2}$ and $v=p_{\mathrm{CO}}/K_{\mathrm{CO}}$, with $K$ values defined on the same pressure basis. For empty, oxygen-bound and CO-bound states,With stipulated $u=9$ and no carbon monoxide, the oxygen-bound fraction is $9/10$. Adding a competing weight $v=9$ changes it to $9/19$ and gives CO the same fraction. These weights are hypothetical; this model omits the cooperative and conformational behavior of real hemoglobin.

The calculation explains why knowing the oxygen partial pressure alone does not identify the amount bound to hemoglobin. Available-site count, competing ligands and binding properties also enter. Even a high occupied fraction among the remaining oxygen-capable sites does not imply that all haem sites are oxygenated.

Co-oximetry separates carboxyhemoglobin from other derivatives using their spectral responses. The 1991 fetal/adult hemoglobin study quantified derivative absorptivities and emphasized that even small spectral differences affect multicomponent analysis.^[ref] Identifying a derivative therefore requires a suitable measurement model; total hemoglobin concentration alone leaves its ligand composition unresolved.

The cholesterol side-chain cleavage enzyme, also designated CYP11A1, is a Cytochrome P450 that converts cholesterol into pregnenolone and 4-Methylpentanal. Its official accepted name is cholesterol monooxygenase (side-chain-cleaving), EC 1.14.15.6. Two hydroxylations precede cleavage between carbon positions 20 and 22.^[ref]

Adrenodoxin supplies electrons to the enzyme; NADPH is an upstream electron source. For the fully coupled net reaction, each pregnenolone formed requires three oxygen molecules and six reduced adrenodoxins. Thus an ideal $1\mu \mathrm{mol}$ conversion consumes $3\mu \mathrm{mol}$ oxygen and six micromoles of one-electron donor equivalents. The carbon balance is $27=21+6$, partitioning the original steroid and its shortened side chain.^[ref]

In 2011, Natalia Mast and colleagues combined X-ray crystallography with solution spectroscopy. Their $2.5\text{A˚}$ structure contained 22R-Hydroxycholesterol, the first intermediate, whose hydroxyl oxygen lay $2.56\text{A˚}$ from the haem iron. Changing adrenodoxin conditions altered carbon monoxide access to reduced haem in a spectroscopic test.^[ref]

Together, these measurements connect substrate positioning with a perturbation in solution. The proposed movement of intermediates during successive reactions is a mechanistic interpretation of the combined evidence; a single structure is a snapshot of one bound state.

A cytochrome is a protein containing a haem group whose iron can change oxidation state during electron transfer. The surrounding protein tunes the properties of the haem and its interactions with electron donors and acceptors. The name denotes a broad biochemical class, not one unique enzyme or one universal reaction. ^[ref]

For example, cytochrome c is a mobile carrier between respiratory complexes, while cytochrome c oxidase is a larger terminal complex that transfers electrons toward oxygen. Carrying an electron and pumping protons are distinct operations; not every individual cytochrome performs both. Spectral changes accompanying oxidation and reduction make these cofactors experimentally useful reporters of electron-transfer state.

Deoxyhemoglobin is the unoxygenated form of hemoglobin whose available haem sites can reversibly bind oxygen. Releasing oxygen produces a binding-state change, rather than the ferric iron state defining methemoglobin. Carboxyhemoglobin differs again because a competing carbon monoxide ligand occupies a binding site. These distinctions matter when interpreting the components of an optical measurement.

In the instrument convention for functional oxygen saturation, HHb denotes the unoxygenated, oxygen-capable component. Its concentration appears with oxyhemoglobin in the denominator:The HHb label is not an instruction to treat deoxygenation as addition of a hydrogen molecule. Functional saturation also uses a different denominator from fractional oxyhemoglobin referenced to total hemoglobin.^[ref]

An original independent-site model illustrates a further counting distinction. Let each of four sites have oxygen-occupancy probability $\theta$, independently. The probability that a tetramer has exactly $m$ occupied sites isAt $\theta =1/2$, half the sites are empty on average, while only $P_0=1/16$ of tetramers have all four sites empty. A haem-equivalent unoxygenated fraction therefore need not equal the fraction of wholly unliganded tetramers. Real hemoglobin binding is cooperative, so independence here is a stated teaching assumption rather than a physiological model.

Deoxyhemoglobin and oxyhemoglobin have distinguishable absorption spectra. A primary study measured the absorptivities of these and other human hemoglobin derivatives across 450–1000 nm, including fetal/adult differences relevant to multicomponent analysis.^[ref] A controlled oxygenation comparison can therefore follow changing spectral contributions without inferring oxygen amount from apparent colour alone. The measured path length, concentrations and calibrated component spectra remain necessary inputs.

Breakdown of haem, including ring cleavage to biliverdin with release of iron, followed by reduction to bilirubin.

Methemoglobin is a hemoglobin derivative with oxidized ferric iron at a haem site. The ferric site cannot perform the usual reversible oxygen binding of an available ferrous site. The distinction is one of oxidation state, not merely whether an oxygen molecule currently occupies the site.^[ref] An adult hemoglobin tetramer contains four haem sites, so site occupancy and the state of the whole tetramer must not be silently conflated.

Deoxyhemoglobin retains the capacity to bind oxygen at its available sites. A ferric site in methemoglobin instead requires chemical reduction to restore the corresponding ferrous state. Formation of oxyhemoglobin is therefore different from accumulating ferric haem. Changes in the surrounding protein also influence the properties of remaining sites; a site-count calculation alone is not a complete cooperative-binding model.

For an original capacity calculation, suppose a sample contains 100 micromoles of haem sites, with 20 micromoles ferric and the other 80 capable of reversible oxygen binding. The latter can bind at most 80 micromoles of oxygen in a one-molecule-per-site model. If 60 micromoles are oxygenated, the oxygenated fraction of all haem sites is $60/100=0.60$, while the occupied fraction of the stipulated capable sites is $60/80=0.75$. A denominator change produces different percentages without changing the sample.

Experimentally, spectrophotometry distinguishes derivatives through calibrated absorption spectra. A 1991 primary study measured human fetal and adult oxyhemoglobin, unoxygenated hemoglobin, carboxyhemoglobin and methemoglobin spectra over 450–1000 nm.^[ref] The relevant inverse problem has the formwhere path length $\ell$, derivative concentrations $c_j$ and their calibrated absorption coefficients determine the modeled absorbance. Co-oximetry uses multiple spectral measurements to estimate such derivative fractions. A single colour observation cannot generally separate several unknown components.

Natalia Mast is the first author of a 2011 study explaining how the cholesterol side-chain cleavage enzyme carries out successive reactions converting cholesterol toward pregnenolone. The investigators studied the enzyme bound to the first oxygenated intermediate, combining a crystal structure with solution measurements.^[ref]

The active site forms an elongated cavity leading toward the haem group. The intermediate's placement and interactions suggested that movement within this cavity permits successive reactions while the sterol remains associated with the enzyme. Solution spectroscopy tested changes in its position.^[ref]

The example illustrates why one catalyst can support a multistep transformation without requiring the intermediate to diffuse freely after every step. A bound structure proposes spatial constraints; measurements in solution test whether the arrangement can change, rather than assuming that a crystal captures the only functional position.

Natallia Strushkevich is the first author of a 2011 structural study of the mitochondrial system that converts cholesterol toward pregnenolone. The team examined the cholesterol side-chain cleavage enzyme together with its electron-transfer partner adrenodoxin.^[ref]

An engineered fusion protein helped hold the partners together for crystal structure determination. The structure related the iron-sulfur cluster of adrenodoxin to the haem group of the catalytic protein, while structures with different bound sterols addressed successive reaction stages.^[ref]

The engineered connection was an experimental aid, not evidence that the native proteins form one continuous chain. Comparing fusion proteins with different linker lengths also tested how the imposed connection affected reduction of the catalytic partner.^[ref] The example connects a useful structure-stabilizing intervention to an explicit check on its functional consequences.

Oxyhemoglobin is oxygen-bound hemoglobin. Binding is reversible: an available haem site can acquire or release an oxygen molecule as conditions change. A fully occupied adult hemoglobin tetramer carries four oxygen molecules, one per haem site.^[ref] Oxygenation describes ligand occupancy and should not be confused with the ferric haem state defining methemoglobin.

A quantitative description must specify its denominator. The manufacturer's functional oxygen saturation iswhere HHb denotes unoxygenated, oxygen-capable hemoglobin. A fractional oxyhemoglobin quantity instead divides by total hemoglobin, including specified non-oxygen-carrying derivatives.^[ref] The concentrations must use a consistent haem-equivalent convention.

For an original four-component example, suppose those equivalent concentrations are 80 units oxyhemoglobin, 5 units deoxyhemoglobin, 10 units carboxyhemoglobin and 5 units methemoglobin. Then functional saturation is $80/85\approx 94.1\%$, whereas the oxyhemoglobin fraction of the full 100-unit total is $80\%$. These describe the same hypothetical mixture with different denominators. Neither percentage alone states the total oxygen amount in a blood volume.

A separate amount calculation assumes 2 micromoles of tetramers, all with four functional sites, at mean occupancy $0.75$. Bound oxygen is thenAny oxygen dissolved outside hemoglobin is an additional pool. Concentration, binding fraction and gas partial pressure are related through a physical model, rather than being interchangeable measurements.

Primary spectral work measured oxyhemoglobin alongside other derivatives, providing coefficient data for distinguishing their contributions to absorbance.^[ref] This connects molecular oxygenation with a measurable optical signal while retaining the distinction between one derivative and the whole sample.

Divergence preserves a structural framework while function changes; convergence produces similar solutions within otherwise different frameworks. Evidence should compare the entire protein fold, the sequence order and connectivity of structural elements, and the geometry of functional residues. Similar activity alone cannot distinguish either history, because many unrelated structures can perform the same reaction.

The globin fold illustrates divergence. myoglobin and the alpha and beta chains of haemoglobin share a predominantly alpha-helical architecture and a homologous pocket for haem. The proximal histidine coordinates the iron, and the surrounding pocket modulates ligand binding. Myoglobin is principally a monomeric oxygen-binding protein, whereas haemoglobin subunits interact within a tetramer to give cooperative oxygen transport. Their conserved core architecture and alignable sequence positions support descent from an ancestral globin, with duplication and subsequent specialization. Structural similarity remains recognizable even when many surface residues have changed. The functional difference arises partly from new intersubunit interactions rather than construction of an entirely new oxygen-binding chemistry.

Trypsin, chymotrypsin and elastase provide a second divergent series. They retain the chymotrypsin-like fold and corresponding catalytic triad residues, but changes in the specificity pocket favour different side chains next to the scissile peptide bond. A negatively charged pocket in trypsin favours basic residues; a hydrophobic pocket in chymotrypsin favours bulky aromatic residues; obstruction of the pocket in elastase favours smaller side chains. Conserved topology, residue correspondence and related sequences support common ancestry. The particular numbering of homologous catalytic residues is useful shorthand, but matching residue numbers alone is not evolutionary evidence.

For convergence, compare chymotrypsin-like proteases with subtilisin. Both are serine proteases using a serine nucleophile, histidine as a proton-transfer partner and an aspartate that organizes the histidine. Both stabilize a tetrahedral intermediate and form an acyl-enzyme. Nevertheless, their global folds differ, and the catalytic residues occur in different orders along the polypeptide: His–Asp–Ser in the chymotrypsin family and Asp–His–Ser in subtilisin. The similar local catalytic arrangement embedded in distinct topologies is evidence for independent assembly of effective serine-protease chemistry. Early three-dimensional structures made comparison of these spatial arrangements possible.^[ref]

The contrast is between a conserved scaffold with modified chemistry or specificity and independently organized scaffolds converging on a favourable active-site geometry. Chemical constraints help explain convergence: catalysis benefits from appropriately positioned acids, bases, nucleophiles and stabilizing charges. They do not require the rest of the protein to become similar.

Structural inference has limits. A common small motif can occur by chance or reflect physical constraints; failure to detect sequence similarity does not prove absence of ancient homology. Strong conclusions combine global structural alignment, sequence-profile comparisons, taxonomic distribution and molecular phylogeny. Domain duplication, rearrangement and loss can complicate a simple family tree. Thus structural resemblance is most persuasive when its extent and topology are evaluated alongside independent evolutionary evidence, rather than classifying every shared helix or catalytic residue as proof of common descent.

A Cytochrome P450 contains an iron–haem centre coordinated by a protein cysteine thiolate. The characteristic spectrum of its reduced carbon-monoxide complex gives the family its name. A common monooxygenation can be writtenOne oxygen atom enters the product and the other is reduced to water. Electron transfer and protonation activate bound oxygen, generating a powerful oxidant such as P450 compound I. Hydrogen abstraction followed by oxygen rebound can hydroxylate a C–H bond, but the family also supports other reactions, including epoxidation and successive oxidation steps. The exact chemistry is enzyme- and substrate-dependent; not every P450 simply performs a single hydroxylation.

This selectivity is valuable for complex natural products. Closely related substrates can differ in the position and stereochemistry of oxygenation, and an enzyme can distinguish sites that are difficult to separate by ordinary chemical synthesis. Oxygenated terpenoid intermediates, drug precursors and other specialized metabolites are therefore attractive targets. The opportunity is selective chemistry, not a guarantee that every plant pathway will be cheap to reproduce in a microbial host.

In an oxygenic photosynthetic chassis, light absorption by photosystem II supports extraction of electrons from water. Transfer through the photosynthetic chain and photosystem I generates reduced ferredoxin, which can feed a compatible P450 directly or contribute to NADPH production for an appropriate reductase system. The distinction matters: native microsomal P450s often use a flavoprotein reductase, whereas engineered direct ferredoxin delivery can bypass that partner. Electrons must still reach the P450 at adequate rates and with correct coupling to substrate oxidation.

There is a clear experimental proof of principle. A plant CYP79A1 catalytic domain was fused to the photosystem-associated PsaM anchor in a cyanobacterium, positioning it near the thylakoid electron supply. Activity was observed in light-driven experiments. This demonstrates functional rerouting of photosynthetic reducing power into a plant P450 reaction, rather than establishing commercial production of a finished pharmaceutical.^[ref]

A production design starts from the entire pathway. Supply a suitable scaffold from endogenous metabolism or introduced enzymes, express the required P450s with compatible membrane anchors and redox partners, and include any downstream transferases or other finishing enzymes. CYP79A1, for example, participates in the pathway to dhurrin; expressing it alone establishes one activity, not the completed multienzyme pathway. For a new high-value oxygenated terpenoid, one must similarly verify every intermediate rather than equating scaffold accumulation with final-product synthesis.

Several constraints can dominate performance. Plant membrane enzymes may fold poorly, insert in the wrong orientation or fail to acquire haem. An abundant P450 may remain inactive because its substrate or electron donor is limiting. Competition with carbon fixation and essential redox metabolism can make maximal electron diversion harmful to growth. Uncoupled oxygen activation can generate reactive oxygen species instead of product. Excess light may increase oxidative damage, while high cell density limits light penetration. Oxygen supply is required for ordinary P450 monooxygenation even though the host produces oxygen photosynthetically.

Optimization should therefore measure carbon flux, enzyme abundance, redox state and products together. Adjust expression ratios, redox-partner choice, subcellular localization and induction timing; relieve precursor bottlenecks without starving essential pathways; and consider export or product capture to limit toxicity. A bioreactor must balance mixing, illuminated surface area, gas exchange and biomass density.

Useful controls include dark incubation, a catalytic-site mutant, pathway-minus strains and perturbation of photosynthetic electron supply while monitoring cell viability. Mass spectrometry and authentic standards establish product identity; oxygen uptake or a fluorescent reporter alone does not. Finally report titre, productivity, carbon yield and stability over repeated cultivation. Light-powered enzyme activity is the biochemical entry point; reliable, selective and economically recoverable product formation is the engineering goal.

These names refer to several unrelated chemical classes: blood and bile pigments, a photosynthetic pigment family, an amino sulfonic acid, a disputed historical faecal extract, and storage polysaccharides or proteins. Similar colour or a historical name does not establish chemical identity.

Haematocrystallin denotes the crystallizable colouring substance of red blood, now identified with hemoglobin. It combines a globin protein with iron-containing haem groups. Within intact red cells it reversibly binds oxygen; oxygenated and deoxygenated forms have different absorption spectra. Crystals obtained from blood differ with species and preparation. This is not the same thing as a crystal formed from an old tissue haemorrhage. The word does not mean that all circulating blood normally consists of free pigment crystals.^[ref]

Haematoidin is the yellow-orange to reddish pigment characteristically encountered in old extravasated blood, sometimes as rhomboidal crystals or radiating clusters. It is associated with bilirubin and lacks the iron retained in haemosiderin. The historical inference that any reddish blood-derived crystal must be the same substance as haematocrystallin is therefore wrong. In a tissue preparation the local matrix and other constituents can complicate an exact chemical identification from appearance alone.^[ref]

Haematin is a dark iron-containing derivative of haem, obtained when the globin association and the iron's chemical environment are altered. In modern chemical usage, hematin is the ferric hydroxide form of the haem pigment; hemin is the corresponding chloride form. Historical preparations and terminology were less consistently separated. Neither should be equated with iron-free bilirubin, and a haem-derived crystal test is not the crystallization of intact hemoglobin.^[ref][ref]

Chlorophyll is the green pigment system of photosynthetic organisms, present in organized pigment-protein assemblies in chloroplasts in green plants. Modern chemistry distinguishes several chlorophylls: chlorophyll a, for example, has a magnesium-containing tetrapyrrolic ring system and a hydrophobic side chain. It absorbs light used in photosynthetic energy conversion. Extraction into alcohol can reveal the green pigment, but a leaf extract is a mixture rather than a chemically pure universal chlorophyll. Its green colour must not be attributed to iron in the same way as haem.^[ref]

Biliverdin is a green, open-chain tetrapyrrolic pigment. In modern haem catabolism, ring cleavage by haem oxygenase releases iron and forms biliverdin; reduction then produces bilirubin. The pigments contribute to changing colours of some resolving haemorrhages and to bile-pigment chemistry. This sequence concerns degradation of the haem group, not conversion of the entire globin protein directly into one green molecule.^[ref]

Taurin, now taurine, is a colourless crystalline amino sulfonic acid with the structure ${\mathrm{H}}_2\mathrm{NC}{\mathrm{H}}_2\mathrm{C}{\mathrm{H}}_2\mathrm{S}{\mathrm{O}}_3\mathrm{H}$. It contains sulfur and nitrogen and can form conjugates with bile acids, including taurocholic acid. It is not itself a green bile pigment, an ordinary carboxylic amino acid, or a standard amino acid directly inserted into proteins by translation. The chemical classification and formula distinguish it from neighbouring names in the list.^[ref]

Excretin was the name William Marcet gave to a crystalline material extracted from human faeces. His contemporary account describes treatment with hot alcohol, removal of material with lime, extraction with ether, and formation of silky needle-like crystals; the material was insoluble in water, soluble in ether and hot alcohol, and melted in the low-to-mid 90s Celsius. His 1859 account reports carbon, hydrogen, oxygen and sulfur and gives an equivalent-weight formula based on an assumed sulfur content. These are historical analytical claims, not a modern authenticated molecular specification. Later work questioned the purity and chemical individuality of excretin, so that old name alone does not establish a definite modern structure.^[ref][ref]

Glycogen is an animal glucose-storage polysaccharide, particularly important in the liver and skeletal muscles. Its highly branched chains contain alpha-(1→4) links with alpha-(1→6) branch points. Preparations form opalescent dispersions and commonly show a reddish-brown iodine reaction rather than the intense blue associated with long amylose chains. Hydrolysis yields glucose. Liver glycogen can support the regulation of circulating glucose, whereas muscle glycogen mainly supports local muscle metabolism; a modern account must distinguish those physiological destinations.^[ref]

Gluten is the cohesive protein-rich material left when wheat dough is washed to remove much of its starch. It is not a single small molecule: modern analysis distinguishes gliadin and glutenin families whose associations contribute extensibility and elasticity. It is poorly soluble in water as a dough network, contains nitrogen, and on full hydrolysis supplies amino acids. Its nutritive role is that of a plant protein mixture, not a nitrogen-free carbohydrate.^[ref]

Legumin is a seed storage globulin associated particularly with peas and related legumes. A classical preparation extracts protein into suitable dilute salt solution and precipitates it under changed conditions. Modern legumins are 11S globulin assemblies, often hexamers formed from processed subunits. They are nitrogen-containing proteins, chemically distinct from starch despite occurring beside it in a seed. The older name vegetable casein indicates an analogy of precipitation or nutritive role; it does not establish identity with milk casein.^[ref]

The liver is both a metabolic processing organ and the producer of bile. These functions must be distinguished: much of what the liver contributes to the body enters the blood, whereas bile is its secretion into the digestive system.

Portal venous blood brings absorbed materials from the alimentary organs to the liver, while the hepatic artery supplies oxygenated blood. Within the hepatic sinusoids, the incoming blood encounters hepatocytes and scavenging Kupffer cells. Hepatocytes take up, transform, store and release substances; their bile canaliculi conduct bile towards the bile ducts. The organ's position therefore makes it a useful regulator between absorption from a meal and supply to the rest of the body.

Its main non-biliary functions include the following:

This modern list extends beyond the knowledge and biochemical vocabulary of 1867. It is consistent with the organ's combined metabolic, storage and clearance roles, rather than treating bile production as the whole explanation.^[ref]

Bile contains water, electrolytes, bile salts, phospholipids, cholesterol and bilirubin conjugates. Hepatocytes form the primary secretion; ductal epithelium modifies it. The gallbladder stores and concentrates bile between meals and releases it into the duodenum. Production of bile must therefore be distinguished from its intermittent delivery to a meal.

Its two central functions are assistance with lipid digestion and nutrient absorption, and excretion of selected waste substances. Amphipathic bile salts help disperse dietary fat and form mixed micelles carrying products of lipid digestion to the absorptive surface of the small intestine. They thereby promote uptake of fatty acids, monoglycerides, cholesterol and fat-soluble vitamins. Bile is not itself a source of pancreatic lipase, nor does emulsification chemically hydrolyse triglycerides. Biliary bilirubin, produced through haem breakdown, provides an excretory route; cholesterol and selected other substances also leave in bile. Most secreted bile salts are recovered, especially in the terminal ileum, and return through the portal vein: the enterohepatic circulation conserves the useful detergent.^[ref]

Two comparisons reveal why both sorts of function matter. First, compare a fresh liver extract with an extract prepared after an appropriate controlled interval: testing for reducing sugar and isolating glycogen distinguishes a stored precursor from newly liberated glucose. A reliable interpretation needs prompt sampling and controls because post-mortem glycogenolysis can change the result after the animal has died; detecting sugar in an organ alone does not prove where all of it was made. Secondly, in classical biliary fistula observations, diverting bile away from the intestine while collecting it separately allowed its output to be measured and the loss of normal fat assimilation to be examined. Comparing faecal fat with and without delivery of bile distinguishes a digestive contribution from a merely excretory one. The modern explanation is that loss of intestinal bile salts impairs mixed micelle formation, while jaundice from retained biliary pigment is a separate consequence of failed pigment elimination.

A porphyrin has a large conjugated ring system built from four nitrogen-containing pyrrole-derived units linked through carbon bridges. Its inner nitrogen atoms can coordinate a metal ion.

An iron-containing porphyrin forms part of haem, while related macrocyclic chemistry occurs in other biological pigments. The conjugated framework supports strong optical absorption, connecting visible color with electronic structure and metal coordination.